Acciones M Pharmaceutical Inc Deutsche Boerse AG
Acciones
CA55346E2050
Biotecnología e investigación médica
Ventas 2018 | 0,75 0,7 | Ventas 2019 | 0,71 0,66 | Capitalización | 3,53 M 3,29 M |
---|---|---|---|---|---|
Resultado Neto 2018 | -5 M -4,67 M | Resultado Neto 2019 | -1 M -934 mil | VE / Ventas 2018 | 4.852.616 x |
Deuda neta 2018 | 319 mil 298 mil | Deuda neta 2019 | 848 mil 791 mil | VE / Ventas 2019 | 6.168.166 x |
P/E ratio 2018 |
-0,6
x | P/E ratio 2019 |
-1,97
x | Empleados | - |
Rendimiento 2018 * |
-
| Rendimiento 2019 |
-
| Flotante | 72,04 % |
Directores | Puesto | Edad | Desde |
---|---|---|---|
Chief Executive Officer | - | 03/01/18 | |
Robert Payment
DFI | Director of Finance/CFO | 42 | - |
Brian Keane
BRD | Director/Board Member | 47 | - |
Administradores | Puesto | Edad | Desde |
---|---|---|---|
Donald Skeith
BRD | Director/Board Member | 69 | 01/12/14 |
William Rodgers
BRD | Director/Board Member | - | - |
Brian Keane
BRD | Director/Board Member | 47 | - |
Varia. 1 de ene. | Capi. | |
---|---|---|
+40,80 % | 53,67 mil M | |
+34,27 % | 38,86 mil M | |
-8,05 % | 38,76 mil M | |
-8,98 % | 27,27 mil M | |
+10,69 % | 25,91 mil M | |
-16,21 % | 20,29 mil M | |
+31,00 % | 12,78 mil M | |
+28,51 % | 12,18 mil M | |
-1,67 % | 11,96 mil M |